BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 17686614)

  • 1. Significance of the expression of phosphorylated-STAT3, -Akt, and -ERK1/2 in several tumors of the epidermis.
    Lin N; Moroi Y; Uchi H; Fukiwake N; Dainichi T; Takeuchi S; Takahara M; Tu Y; Furue M; Urabe K
    J Dermatol Sci; 2007 Oct; 48(1):71-3. PubMed ID: 17686614
    [No Abstract]   [Full Text] [Related]  

  • 2. Overexpression of phosphorylated-ATF2 and STAT3 in cutaneous squamous cell carcinoma, Bowen's disease and basal cell carcinoma.
    Chen SY; Takeuchi S; Moroi Y; Hayashida S; Kido M; Chen SJ; Tomoeda H; Uenotsuchi T; Tu YT; Furue M; Urabe K
    J Dermatol Sci; 2008 Sep; 51(3):210-5. PubMed ID: 18547788
    [No Abstract]   [Full Text] [Related]  

  • 3. Differential expression of ezrin in epithelial skin tumors: cytoplasmic ezrin immunoreactivity in squamous cell carcinoma.
    Park HR; Min SK; Min K; Jun SY; Seo J; Kim KH; Choi J
    Int J Dermatol; 2010 Jan; 49(1):48-52. PubMed ID: 20465611
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical profiling of Wnt, NF-kappaB, Stat3 and Notch signaling in human epidermal tumors.
    Liu ZL; Li Y; Kong QY; Zhan C; Wang Q; Chen XY; Sun Y; Wen S; Tu CX; Liu J; Li H
    J Dermatol Sci; 2008 Nov; 52(2):133-6. PubMed ID: 18703315
    [No Abstract]   [Full Text] [Related]  

  • 5. CCR10 and CCL27 are overexpressed in cutaneous squamous cell carcinoma.
    Kai H; Kadono T; Kakinuma T; Tomita M; Ohmatsu H; Asano Y; Tada Y; Sugaya M; Sato S
    Pathol Res Pract; 2011 Jan; 207(1):43-8. PubMed ID: 21144674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strong expression of a longevity-related protein, SIRT1, in Bowen's disease.
    Hida Y; Kubo Y; Murao K; Arase S
    Arch Dermatol Res; 2007 May; 299(2):103-6. PubMed ID: 17180656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Malignant change in seborrhoeic keratoses in a region with high solar ultraviolet levels.
    Gaffney DC; Muir JB; De'Ambrosis B
    Australas J Dermatol; 2014 May; 55(2):142-4. PubMed ID: 23573958
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of L-type amino acid transporter 1 in various skin lesions.
    Hirano K; Uno K; Kuwabara H; Kojima K; Ohno S; Sakurai H; Kamma H; Kurata A
    Pathol Res Pract; 2014 Oct; 210(10):634-9. PubMed ID: 24939142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of hypoxia-inducible factor-1alpha and hypoxia-inducible factor-2alpha with progression of keratinocytic neoplasms.
    Lining X; Uchi H; Hayashida S; Tsuji G; Kido M; Nakahara T; Takeuchi S; Takahara M; Moroi Y; Furue M
    J Dermatol Sci; 2009 Nov; 56(2):135-6. PubMed ID: 19660915
    [No Abstract]   [Full Text] [Related]  

  • 10. Malignancy arising in seborrheic keratosis: a report of two cases.
    Yap WM; Tan PH; Ong BH
    Ann Acad Med Singap; 1997 Mar; 26(2):235-7. PubMed ID: 9208082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Squamous cell carcinoma, basalioma and Bowen's disease associated with porokeratosis of Mibelli].
    Sawada Y; Adachi A; Hotta R
    Nihon Hifuka Gakkai Zasshi; 1982 Sep; 92(10):1061-4. PubMed ID: 6985287
    [No Abstract]   [Full Text] [Related]  

  • 12. Transformation of seborrheic keratosis into Bowen's disease.
    Bloch PH
    J Cutan Pathol; 1978 Dec; 5(6):361-7. PubMed ID: 154527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phosphorylation state of tumor-suppressor gene p53 product overexpressed in skin tumors.
    Matsumoto M; Furihata M; Kurabayashi A; Ohtsuki Y
    Oncol Rep; 2004 Nov; 12(5):1039-43. PubMed ID: 15492790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical comparison of beta-catenin expression by human normal epidermis and epidermal tumors.
    Fukumaru K; Yoshii N; Kanzaki T; Kanekura T
    J Dermatol; 2007 Nov; 34(11):746-53. PubMed ID: 17973813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of endothelins and their receptors in nonmelanoma skin cancers.
    Zhang Y; Tang L; Su M; Eisen D; Zloty D; Warshawski L; Zhou Y
    J Cutan Med Surg; 2006; 10(6):269-76. PubMed ID: 17241596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 expression in Bowen's disease and in microinvasive squamous cell carcinoma of the skin.
    Hughes JH; Robinson RA
    Mod Pathol; 1995 Jun; 8(5):526-9. PubMed ID: 7675772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the mammalian target of rapamycin signalling pathway in epidermal tumours and its correlation with cyclin-dependent kinase 2.
    Chen SJ; Nakahara T; Takahara M; Kido M; Dugu L; Uchi H; Takeuchi S; Tu YT; Moroi Y; Furue M
    Br J Dermatol; 2009 Feb; 160(2):442-5. PubMed ID: 19016696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of hypoxia-inducible factor-1α, vascular endothelial growth factor and prolyl hydroxylase domain protein 2 in cutaneous squamous cell carcinoma and precursor lesions and their relationship with histological stages and clinical features.
    An X; Xu G; Yang L; Wang Y; Li Y; McHepange UO; Shen G; Tu Y; Tao J
    J Dermatol; 2014 Jan; 41(1):76-83. PubMed ID: 24354513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. P27 and mib1 expression in actinic keratosis, Bowen disease, and squamous cell carcinoma.
    Oh CW; Penneys N
    Am J Dermatopathol; 2004 Feb; 26(1):22-6. PubMed ID: 14726819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Electron microscopic observations of Bowen's disease and arsenical keratosis associated with chronic arsenism (author's transl)].
    Ohyama K; Kuwahara H; Hamada M
    Nihon Hifuka Gakkai Zasshi; 1980; 90(5):397-403. PubMed ID: 6967981
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.